Global University Venturing

The gene therapy developer focused on cardiovascular and central nervous system diseases will merge with Chardan Healthcare Acquisition 2 Corp to list on NYSE.

Stuart Therapeutics has collected equity financing from investors including Wisconsin Alumni Research Foundation to fund phase 2 trials for a drug aimed at dry eye disease.

The portfolio’s fair value rose by 21% and pre-tax profits are up 45% in the first half of Frontier IP’s fiscal year.

Stefanie Tompkins, Colorado School of Mines’ vice-president for research and technology transfer, has been appointed director of Darpa.

Axelys will become the successor to three separate tech transfer organisations in Quebec next month.

Asher Bio has launched with $55m in series A financing to commercialise research partially conducted at WashU and Leiden.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

ActionIQ has pushed its series C round to $100m following an extension from existing shareholders.

The firm specialises in setting up spinouts out of universities and corporations, and now has more than $1.6bn in assets under management.

Parkwalk Advisors has returned to back a $46m round for PhoreMost, weeks after the latter’s spinout Neophore attracted $21m in a series B.